A randomized phase II study of anlotinib combined with STUPP versus STUPP alone in patients with newly diagnosed glioblastoma (GBM)

被引:0
|
作者
Chen, Yuan Yuan Yuan
Dong, Baiqiang
Chen, Zhongping
机构
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Neurosurg Neurooncol, Ctr Canc, Guangzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS2079
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Galectin-1 (Gal-1) expression as a prognostic factor in patients with newly diagnosed glioblastoma (GB) treated with Stupp regimen (GLIOCAT study).
    Vilarino, Noelia
    Martinez-Bosch, Neus
    Balana, Carmen
    Alameda, Francesc
    Estival, Anna
    Pineda, Estela
    del Barco, Sonia
    Gil, Miguel J. Gil
    Mesia, Carlos
    Gallego, Oscar
    Carrato, Cristina
    Ribalta, Teresa
    Sarro, Noemi Vidal
    Balana, Natalia
    Velarde, Jose Maria
    Navarro, Pilar
    Martinez-Garcia, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Randomized phase II study of axitinib alone or combined with lomustine in patients with recurrent glioblastoma.
    Duerinck, Johnny
    Du Four, Stephanie
    Bouttens, Frank
    Verschaeve, Vincent
    Andre, Chantal
    Van Fraeyenhove, Frank
    Chaskis, Cristo
    D'Haene, Nicky
    Le Mercier, Marie
    Salmon, Isabelle
    Neyns, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Phase I/randomized phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM): Final results of phase I study.
    Laack, Nadia N.
    Galanis, Evanthia
    Leinweber, Clinton
    Buckner, Jan C.
    Giannini, Caterina
    Geoffroy, Francois J.
    Jaeckle, Kurt A.
    Sarkaria, Jann Nagina
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Anlotinib plus radiotherapy-temozolomide for newly diagnosed glioblastoma: A prospective, multicenter phase II study.
    Lai, Shuzhen
    Chen, Yuan Yuan Yuan
    Li, Peijing
    Jiang, Fagui
    Liu, Xiaohui
    Tao, Changjuan
    Huang, Jing
    Tang, Yiqiang
    Liu, Zhigang
    Shen, Guoping
    Li, Chaoming
    Xie, Tieming
    Lu, Fangxiao
    Liu, Guihong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] A phase II study of anlotinib combined with temozolomide in the treatment of patients with recurrent glioblastoma.
    Xu, Qingsheng
    Chen, Qun
    Zheng, Xiujue
    Cai, Jinquan
    Zhan, Renya
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] GESTALT (GammaTile Enhanced Stupp Alternative): Feasibility Study of Resection and GammaTile® Followed by Concomitant External Beam Radiation Therapy (EBRT)/Temozolomide (TMZ) and Adjuvant TMZ in Newly Diagnosed Glioblastoma (GBM)
    Dunbar, Erin
    McCracken, David
    Nowlan, Adam
    Dusenbery, Kathryn
    Ferreira, Claire
    Lee, Stuart
    Peach, M. Sean
    Clark, Robert Corns
    Chen, Clark
    NEUROLOGY, 2023, 100 (17)
  • [27] Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma
    Grossman, Stuart A.
    Schreck, Karisa C.
    Ballman, Karla
    Alexander, Brian
    NEURO-ONCOLOGY, 2017, 19 (04) : 469 - 474
  • [28] A RANDOMIZED, PHASE I/II TRIAL OF IXAZOMIB IN COMBINATION WITH STANDARD THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MGMT METHYLATED GLIOBLASTOMA (GBM) STUDY DESIGN
    Kong, Xiao-Tang
    Lai, Albert
    Carrillo, Jose A.
    Fu, Dan Beverly
    Meyskens, Frank
    Bota, Daniela A.
    NEURO-ONCOLOGY, 2018, 20 : 13 - 13
  • [29] A phase I study of capecitabine and concurrent radiotherapy (RT) for patients with newly diagnosed glioblastoma multiforme (GBM).
    Newman, AJ
    Fiveash, J
    Rosenfeld, S
    Johnson, M
    Diasio, R
    Wang, W
    Cockrell-Donohue, AC
    Nabors, LB
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 116S - 116S
  • [30] Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
    Blakeley, Jaishri O.
    Grossman, Stuart A.
    Chi, Andrew S.
    Mikkelsen, Tom
    Rosenfeld, Myrna R.
    Ahluwalia, Manmeet S.
    Nabors, L. Burt
    Eichler, April
    Ribas, Ignacio Garcia
    Desideri, Serena
    Ye, Xiaobu
    CLINICAL CANCER RESEARCH, 2019, 25 (01) : 73 - 79